CAS 1246819-21-5

Formule : C21H30O2

InChI : InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1/i1D3,5D2,6D2,7D2

Code InChI : QHMBSVQNZZTUGM-QFHQIQMYSA-N

SMILES : [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O

(-)-Cannabidiol D9

Produit contrôlé

CAS : 1246819-21-5

Formule : C₂₁H₂₁D₉O₂

Couleur et forme : Neat

Masse moléculaire : 323.52

Ref: 04-CA10946005

Cannabidiol (CBD) D9 100 µg/mL in Acetonitrile

Produit contrôlé

CAS : 1246819-21-5

Formule : C₂₁H₂₁D₉O₂

Couleur et forme : Single Solution

Masse moléculaire : 323.52

Ref: 04-A10946005AL-100

Cannabidiol-d9

Produit contrôlé

CAS : 1246819-21-5

Cannabidiol-d9 is a growth factor that has gained significant attention in recent years. It is derived from the hemp plant and has been shown to have various therapeutic properties. Cannabidiol-d9 can be extracted using methanol and is commonly used in the production of biomass, xylose, and fatty acids. It has also been found to inhibit the effects of certain medications such as palbociclib and ticagrelor. Additionally, cannabidiol-d9 has been shown to have positive effects on glutamate levels in the brain, making it potentially beneficial for individuals with neurological disorders. Controlled products containing cannabidiol-d9 are often used in the production of cellulose-based materials, such as papers and textiles. Furthermore, this compound has been found to have antimicrobial properties against sulfadiazine-resistant bacteria and can enhance the activity of glycine receptors. Some skincare products also incorporate chamomile extract and tocopherol along with cannabidiol-d

Formule : C₂₁H₃₀O₂

Degré de pureté : Min. 95%

Masse moléculaire : 323.5 g/mol

Ref: 3D-WZB81921